BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23808814)

  • 1. Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan.
    Kimura H; Karube K; Ito Y; Hirano K; Suzuki M; Iwata S; Seto M
    Leuk Lymphoma; 2014 Apr; 55(4):962-3. PubMed ID: 23808814
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
    Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
    Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
    Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.
    Bouchekioua A; Scourzic L; de Wever O; Zhang Y; Cervera P; Aline-Fardin A; Mercher T; Gaulard P; Nyga R; Jeziorowska D; Douay L; Vainchenker W; Louache F; Gespach C; Solary E; Coppo P
    Leukemia; 2014 Feb; 28(2):338-48. PubMed ID: 23689514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
    Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
    Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.
    Sato T; Okano T; Tanaka-Kubota M; Kimura S; Miyamoto S; Ono S; Yamashita M; Mitsuiki N; Takagi M; Imai K; Kajiwara M; Ebato T; Ogata S; Oda H; Ohara O; Kanegane H; Morio T
    Pediatr Int; 2016 Oct; 58(10):1076-1080. PubMed ID: 27593409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent somatic
    Xiao W; Gupta GK; Yao J; Jang YJ; Xi L; Baik J; Sigler A; Kumar A; Moskowitz AJ; Arcila ME; Raffeld M; Pittaluga S; Dogan A; Jaffe ES
    Blood; 2019 Sep; 134(12):986-991. PubMed ID: 31383643
    [No Abstract]   [Full Text] [Related]  

  • 8. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype.
    Stepensky P; Keller B; Shamriz O; NaserEddin A; Rumman N; Weintraub M; Warnatz K; Elpeleg O; Barak Y
    Clin Immunol; 2016 Feb; 163():91-5. PubMed ID: 26769277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings.
    Yang CF; Hsu CY; Ho DM
    Histopathology; 2018 May; 72(6):955-964. PubMed ID: 29314186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
    Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
    Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Chang BH; Stork L; Fan G
    Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
    Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
    Genes Chromosomes Cancer; 2016 May; 55(5):460-71. PubMed ID: 26773734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.
    Bains T; Heinrich MC; Loriaux MM; Beadling C; Nelson D; Warrick A; Neff TL; Tyner JW; Dunlap J; Corless CL; Fan G
    Leukemia; 2012 Sep; 26(9):2144-6. PubMed ID: 22425895
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of benign natural killer cell proliferative disorder of the stomach (gastric manifestation of natural killer cell lymphomatoid gastroenteropathy) mimicking extranodal natural killer/T-cell lymphoma.
    Yamamoto J; Fujishima F; Ichinohasama R; Imatani A; Asano N; Harigae H
    Leuk Lymphoma; 2011 Sep; 52(9):1803-5. PubMed ID: 21649544
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
    Jeong EG; Kim MS; Nam HK; Min CK; Lee S; Chung YJ; Yoo NJ; Lee SH
    Clin Cancer Res; 2008 Jun; 14(12):3716-21. PubMed ID: 18559588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
    Bergmann AK; Schneppenheim S; Seifert M; Betts MJ; Haake A; Lopez C; Maria Murga Penas E; Vater I; Jayne S; Dyer MJ; Schrappe M; Dührsen U; Ammerpohl O; Russell RB; Küppers R; Dürig J; Siebert R
    Genes Chromosomes Cancer; 2014 Apr; 53(4):309-16. PubMed ID: 24446122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
    Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
    Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia.
    Bellanger D; Jacquemin V; Chopin M; Pierron G; Bernard OA; Ghysdael J; Stern MH
    Leukemia; 2014 Feb; 28(2):417-9. PubMed ID: 24048415
    [No Abstract]   [Full Text] [Related]  

  • 20. JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications.
    de Martino M; Gigante M; Cormio L; Prattichizzo C; Cavalcanti E; Gigante M; Ariano V; Netti GS; Montemurno E; Mancini V; Battaglia M; Gesualdo L; Carrieri G; Ranieri E
    Urol Oncol; 2013 Aug; 31(6):930-7. PubMed ID: 21868263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.